IQ-001

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIQ-001
Drug Alias NameIQ-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterleukin-17F inhibitors
TargetsInterleukin-17F
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunoQure AG
China Registration ClassN/A

Develop Information

Active CompaniesImmunoQure AG
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A